YAP1 can regulate the sensitivity of cancer cells to drugs through various mechanisms, such as the HIPPO-YAP1-transcriptional enhancer associate domain (TEAD) signaling pathway, stem cell markers, and increased expression of ABC transporter proteins; however, all these mechanisms must rely on YAP1 entering the nucleus for this to occur [37,38]. This evidence concerns the gene ABCG2 and cancer.